Evidence map›Paper›PMID 36826361›Full record

ArticleGeriatrics (Basel, Switzerland)2023

A Molecular and Epidemiological Investigation of a Large SARS-CoV-2 Outbreak in a Long-Term Care Facility in Luxembourg, 2021.

Corinna Ernst, Yolanda Pires-Afonso, Dritan Bejko, Conny Huberty, Thomas G Dentzer, Anke Wienecke-Baldacchino, Eric Hugoson, Daniel Alvarez, Murielle Weydert, Anne Vergison and 1 more

Open access · goldAbstract read
In one paragraph

Article in Geriatrics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Corinna ErnstLuxembourg Health Directorate, L-1273 Luxembourg, Luxembourg.
Yolanda Pires-AfonsoLuxembourg Health Directorate, L-1273 Luxembourg, Luxembourg.ORCID 0000-0002-5773-414X
Dritan BejkoLuxembourg Health Directorate, L-1273 Luxembourg, Luxembourg.
Conny HubertyLuxembourg Health Directorate, L-1273 Luxembourg, Luxembourg.
Thomas G DentzerLuxembourg Health Directorate, L-1273 Luxembourg, Luxembourg.
Anke Wienecke-BaldacchinoLaboratoire National de Santé, L-3583 Dudelange, Luxembourg.
Eric HugosonLaboratoire National de Santé, L-3583 Dudelange, Luxembourg.
Daniel AlvarezLaboratoire National de Santé, L-3583 Dudelange, Luxembourg.
Murielle WeydertLuxembourg Health Directorate, L-1273 Luxembourg, Luxembourg.
Anne VergisonLuxembourg Health Directorate, L-1273 Luxembourg, Luxembourg.
Joël MossongLuxembourg Health Directorate, L-1273 Luxembourg, Luxembourg.
Luxembourg Institute of Health · LULaboratoire National de Santé · LU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In spring 2021, a long-term care facility (LTCF) of 154 residents in Luxembourg experienced a large severe, acute respiratory-syndrome coronavirus 2 (SARS-CoV-2) outbreak a few days after a vaccination campaign. We conducted an outbreak investigation and a serosurvey two months after the outbreak, compared attack rates (AR) among residents and staff, and calculated hospitalization and case-fatality rates (CFR). Whole genome sequencing (WGS) was performed to detect variants in available samples and results were compared to genomes published on GISAID. Eighty-four (55%) residents and forty-five (26%) staff members tested positive for SARS-CoV-2; eighteen (21%) residents and one (2.2%) staff member were hospitalized, and twenty-three (CFR: 27%) residents died. Twenty-seven (21% of cases) experienced a reinfection. Sequencing identified seventy-seven cases (97% of sequenced cases) with B.1.1.420 and two cases among staff with B.1.351. The outbreak strain B.1.1.420 formed a separate cluster from cases from other European countries. Convalescent and vaccinated residents had higher anti-SARS-CoV-2 IgG antibody concentrations than vaccinated residents without infection (98% vs. 52%, respectively, with >120 RU/mL,

Indexed as

antibodiesCOVID-19elderlyinfection controlmortalitynursing homeoutbreakpublic healthSARS-CoV-2whole genome sequencing

Identifiers

PMID36826361
PMCPMC9957261
OpenAlexW4318206257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.